ClinicalTrials.Veeva

Menu

Performance of IGRAs for TB Infection Diagnosis in Elderly (IGRage)

A

Assistance Publique - Hôpitaux de Paris

Status

Terminated

Conditions

Tuberculosis
Ageing

Treatments

Other: Blood samples

Study type

Observational

Funder types

Other

Identifiers

NCT01895582
2012-A00326-37 (Other Identifier)
P110131

Details and patient eligibility

About

Background: Diagnosis and screening for latent tuberculosis in old patients is of special interest in regards of the morbidity-mortality of this disease in that context.

TB-infection diagnosis based on immunological memory detection can be impaired with age. New blood tests (QFTB-G and T-SPOT.TB) specific for MTB infection have not been evaluated in those old patients.The primary endpoint of this study is the evaluation of the IGRAS for active TB diagnosis in patients above 75 years old.

Full description

In vitro Interferon Gamma releasing Assay (IGRA) are recommended for LTBI screening as or instead of TST, but there accuracy in those old patients are not known: as immune responses are impaired in elderly and some of them have already met M tuberculosis before active antibiotherapy exists.The aim of this study is to evaluate characteristics of the two commercials tests IGRA T-spot-TB® and Quantiferon-TB-gold- in tube® and TST in old patients with or without active Tuberculosis.

Principal outcome:

  • 3 tests performance for active TB diagnosis in patients older than 75 years-old

Secondary outcomes :

  • concordance between IGRAs.
  • non-concordant results analysis
  • concordance of IGRAs results with time of TB-infection
  • biobank

Methodology :Diagnostic test performance study

Enrollment

160 patients

Sex

All

Ages

75+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 75 years
  • Consent signed
  • hospitalized patient with start treatment of Tuberculosis disease
  • French social right

Exclusion criteria

  • Tuberculosis disease treatment since 7 days
  • No 3 months follow-up possible
  • Immunosuppression

Trial design

160 participants in 3 patient groups

Active TB-infected patients
Description:
TB-infected patients with bacteriological and histological evidences
Treatment:
Other: Blood samples
Non active TB-infected patients (already met TB)
Description:
some of elders have already met M tuberculosis before active antibiotherapy exists
Treatment:
Other: Blood samples
Non active TB-infected patients (other diagnosis)
Description:
same symptoms than two others groups but an other diagnosis
Treatment:
Other: Blood samples

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems